08.10.16
Mark Adams has been appointed vice president of project management, Paragon Bioservices. Mr. Adams will be responsible for directing the project management team.
Mr. Adams brings more than 30 years of industry experience from companies such as Shire Human Genetic Therapies, Genzyme Transgenics, Lonza Biologics and, most recently, Cytovance Biologics, where he established a program management team that drove milestone deliverables for over 25 client process development and GMP manufacturing programs. He also has extensive knowledge and experience in biologic drug development.
"We are very pleased to welcome Mark to Paragon's management team. He brings a proven track record of accomplishment in building project management systems and teams that drive commercial growth. We welcome his leadership and experience and are confident he will significantly strengthen our operation," said Pete Buzy, president of Paragon.
Mr. Adams brings more than 30 years of industry experience from companies such as Shire Human Genetic Therapies, Genzyme Transgenics, Lonza Biologics and, most recently, Cytovance Biologics, where he established a program management team that drove milestone deliverables for over 25 client process development and GMP manufacturing programs. He also has extensive knowledge and experience in biologic drug development.
"We are very pleased to welcome Mark to Paragon's management team. He brings a proven track record of accomplishment in building project management systems and teams that drive commercial growth. We welcome his leadership and experience and are confident he will significantly strengthen our operation," said Pete Buzy, president of Paragon.
